CG Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

CG Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$970K	Buy	21,625 +6,530	+43%	+$320K	0.36%	81
2016 Q3	$843K	Buy	15,095 +8,200	+119%	+$457K	0.32%	86
2016 Q2	$345K	Sell	6,895 -13,565	-66%	-$666K	0.14%	98
2016 Q1	$939K	Sell	20,460 -5,900	-22%	-$286K	0.38%	66
2015 Q4	$1.62M	Buy	26,360 +15,760	+149%	+$1.11M	0.65%	50
2015 Q3	$590K	Buy	+10,600	New	+$667K	0.25%	83

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

CG Asset Management's KITE Position: Q4 2016 in Review

CG Asset Management increased its Kite Pharma, Inc. (KITE) stake by 43% in Q4 2016, buying an estimated $320K and bringing the position to 21,625 shares worth $970K. The position accounts for 0.36% of the portfolio, ranked #81.

CG Asset Management first reported a position in KITE in Q3 2015 and has held it in 6 quarters since. The position peaked at $1.62M in Q4 2015. 184 funds tracked by Wall St. Rank hold KITE as of Q4 2016.

CG Asset Management held 21,625 shares of Kite Pharma, Inc. worth $970K as of Q4 2016.
CG Asset Management bought 6,530 Kite Pharma, Inc. shares in Q4 2016, an estimated $320K.
Kite Pharma, Inc. made up 0.36% of CG Asset Management's portfolio in Q4 2016, its #81 holding.
CG Asset Management first reported a position in Kite Pharma, Inc. in Q3 2015 and has held it in 6 quarters since.
CG Asset Management's Kite Pharma, Inc. position peaked at $1.62M in Q4 2015.
184 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.